NSZOZ Termedica Centrum Badan Klinicznych
Poznan 60-681
2 studies enrolling now · 5 studies all time
What they study most
Moderately to Severely Active Crohn Disease, Primary Sjogrens Disease, Ulcerative Colitis
Studies at this site
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Recruiting now
- Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — Recruiting now
- ABTECT - Maintenance — Running, not enrolling
- A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
- ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed